Answers are grounded in this paper and cite their sources.
Demonstrates the efficacy of a novel MXene nanoplatform in enhancing chemotherapy and immunotherapy for bladder cancer, implying improved treatment outcomes.
Bladder cancer is a major clinical challenge due to high recurrence and limited efficacy of conventional therapies, creating an urgent demand for localized and targeted strategies. In this study, we...
No takes yet. Share an insight, caveat, or question.
peng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: